Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Credit Suisse Maintains Outperform on Home Point Capital, Lowers Price Target to $3.5

Author: Benzinga Newsdesk | November 21, 2022 09:53am
Credit Suisse analyst Douglas Harter maintains Home Point Capital (NASDAQ:HMPT) with a Outperform and lowers the price target from $4 to $3.5.

Posted In: HMPT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist